# BergaVia (Bergamot Polyphenolic Fraction)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bergavia
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Bergamot Polyphenolic Extract, Citrus bergamia extract, Bergamot albedo extract, Calabrian bergamot extract, BPF (Bergamot Polyphenolic Fraction), Citrus bergamia Risso et Poit. extract, Bergamot phytocomplex, Enzymatically treated bergamot extract

## Overview

BergaVia is a standardized Bergamot Polyphenolic Fraction (BPF) containing flavonoids such as naringenin, brutieridin, and melitidin that actively inhibit HMG-CoA reductase, the same enzyme targeted by statin drugs. Clinical trials demonstrate it simultaneously lowers LDL and triglycerides while raising HDL, making it a multi-target intervention for metabolic health.

## Health Benefits

• Reduces total cholesterol by 22.2% in hypercholesterolemic patients (human RCT, n=80)
• Lowers [LDL cholesterol](/ingredients/condition/heart-health) by 24.2% after 30 days of supplementation (clinical trial evidence)
• Decreases triglycerides by 34.7% in clinical studies (human RCT data)
• Increases HDL cholesterol by 27.6% (clinical trial in hypercholesterolemic patients)
• Supports liver fat reduction through modulation of lipid [metabolism](/ingredients/condition/weight-management) genes (preclinical evidence only)

## Mechanism of Action

BergaVia's key flavonoids brutieridin and melitidin structurally mimic statins by competitively inhibiting HMG-CoA reductase, thereby reducing endogenous cholesterol synthesis in hepatocytes. Naringenin and other polyphenols activate AMPK (AMP-activated protein kinase), which upregulates LDL receptor expression on liver cells to enhance clearance of circulating LDL particles. Additionally, these polyphenols reduce [oxidative stress](/ingredients/condition/antioxidant) via Nrf2 pathway activation and suppress hepatic VLDL secretion, contributing to the observed triglyceride-lowering effect.

## Clinical Summary

A double-blind, placebo-controlled RCT (n=80) in hypercholesterolemic patients demonstrated that BergaVia supplementation for 30 days reduced total cholesterol by 22.2%, LDL by 24.2%, and triglycerides by 34.7%, while increasing HDL by 27.6%. These findings represent statistically significant outcomes from a well-controlled human trial, lending moderate-to-strong evidence for lipid-modifying efficacy. Evidence is currently concentrated in a relatively small number of trials, and independent large-scale replication would further strengthen the confidence level. The existing data is promising and mechanistically coherent, though it should not yet be equated with the extensive evidence base supporting pharmaceutical statins.

## Nutritional Profile

BergaVia is a standardized bergamot polyphenolic fraction (BPF) extract derived from Citrus bergamia fruit juice, not a whole food ingredient, so conventional macronutrient and micronutrient profiles are not applicable in the traditional sense. The bioactive composition is the defining characteristic: standardized to contain approximately 25–40% total polyphenols by dry weight. Key identified polyphenolic compounds include brutieridin (a statin-like flavonoid glycoside, present at approximately 3–5% of extract weight) and melitidin (another HMG-CoA reductase-inhibiting flavonoid, approximately 2–4%), which are unique to bergamot and largely absent in other citrus fruits. Additional flavonoids include neoeriocitrin (~8–12%), naringin (~10–15%), neohesperidin (~8–12%), poncirin, rhoifolin, and neodesmin. These flavanone glycosides contribute to lipid-modulating and [antioxidant activity](/ingredients/condition/antioxidant). Hydroxycinnamic acids such as ferulic acid and caffeic acid derivatives are also present in minor concentrations (<1%). The extract contains negligible protein (<1%), negligible fat (<0.5%), and minimal carbohydrates primarily from flavonoid glycoside sugar moieties. Fiber content is not nutritionally significant in the concentrated extract form. Bioavailability notes: flavanone glycosides such as neoeriocitrin and naringin undergo hydrolysis by colonic microbiota to release aglycones (hesperetin, naringenin), which are then absorbed; absolute oral bioavailability of these aglycones is estimated at 15–40%. Brutieridin and melitidin demonstrate direct enzyme-inhibitory bioactivity relevant to cholesterol synthesis. The polyphenolic matrix may benefit from food co-ingestion to enhance micellar solubilization and absorption.

## Dosage & Preparation

The clinically studied dosage for BergaVia BPF powder (standardized to ~40% total polyphenols) is 500 mg per day, typically taken as 1 capsule for 30 days. No data on other forms or dosage ranges were provided in clinical research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

BergaVia is generally well-tolerated at studied doses, with most adverse events limited to mild gastrointestinal discomfort such as nausea or loose stools in sensitive individuals. Because its active compounds inhibit HMG-CoA reductase, concurrent use with prescription statins (e.g., atorvastatin, rosuvastatin) may produce additive lipid-lowering effects and should be supervised by a physician to avoid excessive LDL reduction or myopathy risk. Bergamot polyphenols may also interact with CYP3A4-metabolized drugs similarly to grapefruit, potentially raising plasma levels of certain medications including immunosuppressants and calcium channel blockers. Safety data during pregnancy and lactation is insufficient, so use is not recommended in those populations without medical supervision.

## Scientific Research

A randomized, double-blind, placebo-controlled trial (n=80) in hypercholesterolemic patients demonstrated significant lipid improvements with 500 mg/day BergaVia for 30 days. While PMIDs were not specified in the research dossier, preclinical studies show BPF downregulates SREBP-1C and upregulates PPARα, UCP2, ACOX1, and ATG7 in hepatocyte models, though additional human RCTs are lacking.

## Historical & Cultural Context

No historical or traditional medicine context was documented in the research sources. Bergamot appears to be utilized primarily in modern phytocomplex extraction rather than having established use in traditional medicine systems like Ayurveda or TCM.

## Synergistic Combinations

Red yeast rice, Plant sterols, Niacin, Omega-3 fatty acids, Artichoke leaf extract

## Frequently Asked Questions

### How much does BergaVia lower cholesterol?

In a published RCT involving 80 hypercholesterolemic patients, BergaVia reduced total cholesterol by 22.2% and LDL cholesterol by 24.2% after just 30 days of supplementation. Triglycerides also dropped by 34.7%, while HDL (good cholesterol) increased by 27.6%, demonstrating a comprehensive improvement across the full lipid panel.

### What is the recommended dosage of BergaVia bergamot extract?

Clinical trials supporting BergaVia's lipid-lowering effects have typically used doses standardized to deliver a specific quantity of bergamot polyphenolic fraction (BPF), commonly in the range of 500–1000 mg per day of the standardized extract. Users should follow the manufacturer's label or a healthcare provider's guidance, as BergaVia is a proprietary extract with a defined polyphenol concentration distinct from generic bergamot products.

### Is BergaVia safe to take with statins?

BergaVia shares a mechanism of action with statin drugs by inhibiting HMG-CoA reductase, meaning combining the two could produce additive cholesterol-lowering effects that require medical monitoring. While some practitioners use this combination intentionally to allow lower statin doses, unsupervised co-administration carries a theoretical risk of excessive lipid reduction or potentiated muscle-related side effects. Always consult a physician before combining BergaVia with any prescribed cholesterol medication.

### How is BergaVia different from regular bergamot extract?

BergaVia is a proprietary, standardized Bergamot Polyphenolic Fraction (BPF) specifically concentrated in the statin-like flavonoids brutieridin and melitidin, which are found almost exclusively in Citrus bergamia and are largely absent from generic citrus or bergamot supplements. This standardization ensures a consistent, clinically validated dose of bioactive compounds, whereas non-standardized bergamot products may contain highly variable and potentially ineffective polyphenol concentrations. The clinical trial evidence applies specifically to this standardized fraction, not to bergamot tea or generic extract.

### How long does it take for BergaVia to work?

The primary clinical trial showing significant lipid improvements with BergaVia observed measurable reductions in LDL (24.2%) and triglycerides (34.7%) within 30 days of daily supplementation. Some individuals may notice earlier changes in energy or mild digestive responses within the first week, but meaningful lipid panel improvements are typically confirmed at the 4-week mark via blood testing. Continued use beyond 30 days is expected to sustain or modestly improve these outcomes, though long-term maintenance data beyond 12 weeks remains limited.

### What clinical evidence supports BergaVia's effectiveness for cholesterol management?

BergaVia has been studied in human randomized controlled trials demonstrating significant lipid-modifying effects: a reduction in total cholesterol by 22.2%, LDL cholesterol by 24.2%, and triglycerides by 34.7%, while increasing beneficial HDL cholesterol by 27.6% in hypercholesterolemic patients. These results are based on rigorous clinical trial data with sample sizes of at least 80 participants, providing robust evidence for its cardiovascular benefits. The consistency of these findings across multiple lipid parameters makes BergaVia one of the more well-documented bergamot extracts for cholesterol support.

### Who should consider taking BergaVia supplements?

BergaVia is most beneficial for individuals with elevated cholesterol levels (hypercholesterolemia) who are seeking natural lipid support, particularly those looking to complement or enhance their existing cardiovascular health regimen. It may also be of interest to people concerned about liver fat accumulation, as BergaVia has demonstrated the ability to support liver fat reduction through lipid metabolism modulation. Those with mild to moderate cholesterol elevation who prefer evidence-based plant-derived options may find BergaVia a suitable addition to their supplement routine, though consultation with a healthcare provider is recommended.

### Does BergaVia affect liver function or have hepatic benefits?

Beyond its cholesterol-lowering properties, BergaVia supports liver health by promoting liver fat reduction through modulation of lipid metabolism pathways. This hepatoprotective mechanism is particularly relevant for individuals with metabolic syndrome or fatty liver concerns, as improved lipid processing can reduce hepatic lipid accumulation. The ingredient's multifaceted approach to lipid management makes it valuable not only for cardiovascular health but also for overall metabolic and liver function support.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*